Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine in Opioid-Related Disorders
NCT00000207Phase 3Completed
- Sponsor
- University of California, Los Angeles
- Start
- May 1992
- Primary completion
- Apr 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by University of California, Los Angeles. Started May 1992; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000207.